Genus plc (GB:GNS) has released an update.
Genus plc faced a challenging year with a decrease in revenue and profits, but strategic management actions and structural changes mitigated the impact, resulting in improved performance in the second half of the year. Despite difficult market conditions, particularly in China, the company achieved strategic progress, including advancements with their Porcine Reproductive and Respiratory Syndrome (PRRS) Resistant Pig and the initiation of the ABS Value Acceleration Programme expected to deliver further financial benefits in the upcoming year. Genus plc expresses confidence in achieving significant growth in adjusted profit before tax for FY25, corresponding with market expectations, while also noting potential currency headwinds.
For further insights into GB:GNS stock, check out TipRanks’ Stock Analysis page.
